BioSkryb Genomics, based in Durham, NC, is a leading provider of innovative single-cell analysis solutions that enable researchers to uncover the complex molecular characteristics of genomics. Their patented technologies, including Primary Template-directed Amplification (PTA) and the BaseJumper bioinformatics platform, allow for a more comprehensive understanding of the relationship between genes and disease, advancing the development of precise treatments.
With a focus on resolving cellular heterogeneity, BioSkryb empowers researchers to analyze down to the single-cell level, providing insights into the variations in DNA that drive human diversity and the development of diseases like cancer. Their products, such as ResolveOME and ResolveDNA, offer unified workflows and unprecedented genome recovery, amplification, and coverage uniformity, revolutionizing the field of genomics and enabling breakthrough discoveries.
Generated from the website